| |
| |
|
|
A BILL TO BE ENTITLED
|
|
|
AN ACT
|
|
|
relating to the closed formulary for workers' compensation |
|
|
pharmaceutical benefits. |
|
|
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: |
|
|
SECTION 1. Section 408.028, Labor Code, is amended by |
|
|
adding Subsection (b-1) to read as follows: |
|
|
(b-1) The commissioner shall adopt rules allowing the |
|
|
compounding of any drug formulation that incorporates any drug or |
|
|
combination of drugs contained in the closed formulary, regardless |
|
|
of the form in which the drug or drugs are approved in the |
|
|
formulary, to be eligible for reimbursement if: |
|
|
(1) a health care practitioner directs that the |
|
|
compounded drug formulation be dispensed to the patient under a |
|
|
prescription as an oral, parenteral, rectal, vaginal, buccal, |
|
|
transdermal, topical, or inhalant medication; and |
|
|
(2) a commercially available version of the compounded |
|
|
drug formulation is not available in the form and concentration |
|
|
prescribed by the health care practitioner. |
|
|
SECTION 2. This Act takes effect September 1, 2011. |